š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The main purpose of this Phase II study was to assess the safety and immuno...
Status
Completed
Location
Investigational Site Number :8400003
Start Date
2021-07-16
Trial ID
NCT04969276
Treatments Being Tested
In solid organ transplant (SOT) the receipt of influenza vaccine in an infl...
Status
Completed
Location
University of Minnesota
Start Date
2023-09-11
Trial ID
NCT05663463
Treatments Being Tested
The purpose of this study is to evaluate Immunogenicity and Safety of a Hig...
Status
Completed
Location
CenExel CNS- Site Number : 8400005
Start Date
2024-11-04
Trial ID
NCT06641180
The overall aim of the study is to compare safety and immunogenicity of ina...
Status
Completed
Location
Centers for Disease Control and Prevention
Start Date
2017-08-28
Trial ID
NCT03183908
Treatments Being Tested
Hypothesis 1: The safety profile in adult allogeneic stem cell hematopoieti...
Status
Completed
Location
Vanderbilt-Ingram Cancer Center, Clinical Trials Information Program
Start Date
2010-10
Trial ID
NCT01215734
This pilot research trial studies the antibody response to high-dose season...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2017-10-17
Trial ID
NCT04484532
Treatments Being Tested
This is a Phase I, first-in-human, randomized, modified double-blind, activ...
Status
Completed
Location
AES - DRS - Optimal Research_Site 8400007
Start Date
2022-06-09
Trial ID
NCT05426174
Treatments Being Tested
This was a Phase 1/2, randomized, observer-blinded, active-controlled trial...
Status
Completed
Location
Research Site US108
Start Date
2017-09-18
Trial ID
NCT03293498
Treatments Being Tested
Primary Objective: To demonstrate the superior relative effectiveness of Q...
Status
Terminated
Location
Investigational Site Number 2469999
Start Date
2019-11-04
Trial ID
NCT04137887
Study FBP00005 is planned to be a translational Phase I, randomized, modifi...
Status
Completed
Location
Investigational Site Number : 0360002
Start Date
2024-08-12
Trial ID
NCT06507553